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Nova bandagem ajustável das artérias pulmonares na síndrome de hipoplasia de câmaras esquerdas
A novel adjustable pulmonary artery banding
system for hypoplastic left heart syndrome
Abstract
Objective: Hypoplastic left heart syndrome remains a
challenge for worldwide surgeons. Initial palliation
employing bilateral pulmonary artery banding along with
ductal stent implantation and atrial septostomy has been
proposed as an alternative approach. However, the surgically
placed bands are fixed and may become inadequate after
sternum closure or with somatic growth of the patient. We
describe the first case in which a neonate with hypoplastic
left heart syndrome was initially managed using a mini
banding system that allows for fine percutaneous adjustments
of pulmonary blood flow.
Method: Through a mid sternotomy, a 5 day-old neonate
underwent bilateral pulmonary artery banding using this
new system combined with placement of a main pulmonary
artery to innominate artery shunt.
Results: The patient had an uneventful postoperative
course. Three percutaneous adjustments of the banding
system were necessary to keep the arterial oxygen saturation
in the 75%-85% range. On the 48th day of life, she was
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INTRODUCTION
The traditional surgical approach of newborns with
hypoplastic left heart syndrome is complex and continues
to have significant mortality compared with other neonatal
cardiac operations [1 ]. Single ventricle palliation with the
Norwood operation and a systemic-to-pulmonary shunt aims
at redirecting circulatory pathways to protect the pulmonary
vasculature from excessive blood flow and optimize systemic
organ flows. However, some overloading of the systemic
right ventricle still persists after this operation. Also, such
major surgical procedures are usually performed in the
neonatal period (sometimes in a low-birth weight patient
and with unfavorable anatomy), which may result in sub-
optimal neurological outcomes in the long-term.
An alternative approach for palliation of hypoplastic left
submitted to stent placement (6 mm) within the atrial septum
to treat a restrictive atrial septal defect. The Norwood
operation and the bidirectional Glenn shunt were carried
out on the 106th day of life. The bands were removed with no
distortion of the pulmonary arteries.
Conclusions: The clinical use of this innovative pulmonary
artery banding system was feasible, safe and effective. It
allowed for customization of the pulmonary blood flow
according to the underlying clinical needs, resulting in a
more precise balance between the pulmonary and systemic
circulations.
Descriptors: Heart defects, congenital. Stents. Palliative
care. Hypoplastic left heart syndrome. Pulmonary artery,
surgery. Balloon dilatation.
Resumo
Objetivo: A Síndrome de Hipoplasia de Câmaras Esquerdas
representa um grande desafio para cirurgiões do mundo
inteiro. Atualmente, tem sido proposto procedimento paliativo
alternativo, por meio da bandagem bilateral das artérias
pulmonares associada à colocação de stent no canal arterial e
atrioseptostomia. No entanto, as bandagens utilizadas são
fixas, podendo tornar-se inadequadas após o fechamento do
esterno ou com o rápido crescimento somático do paciente.
Descrevemos a primeira aplicação clínica do novo dispositivo
heart in the neonatal period, first recommended by Gibbs et
al. [2], has been stenting the arterial duct in combination
with branch pulmonary artery banding and atrial septostomy,
as needed [3-5]. At present, most of the technical challenges
have been elucidated [6]. Currently, the hybrid stage I
palliation is considered the preferred therapeutic approach
in high-risk neonates [7,8]. However, fine adjustments of the
amount of pulmonary blood flow, which is a critical issue,
has proved to be a particularly difficult aspect of the
procedure. This can be readily explained when it is recalled
that Poiseuille’s law predicts that blood flow is related to
the fourth power of the radius of the vessel [9,10].
Therefore, a minor alteration in diameter will have a large
impact on flow and pressure gradient across the band site.
Generally, the bands are surgically adjusted (tighten or
loosened), based on pressure measurements and arterial
miniaturizado de bandagem ajustável das artérias
pulmonares em neonato portador da síndrome de hipoplasia
de câmaras esquerdas, o qual permitiu ajustes percutâneos
precisos do fluxo sangüíneo pulmonar.
Método: Através de esternotomia mediana, neonato de 5
dias de vida foi submetido à bandagem pulmonar bilateral,
usando este novo dispositivo, combinada com interposição de
tubo de PTFE entre o tronco pulmonar e o tronco
braquiocefálico.
Resultados: O paciente apresentou boa evolução pós-
operatória. Três ajustes percutâneos das bandagens foram
necessários para manter a saturação arterial de oxigênio
entre 75-85%. No 48o dia de vida, o paciente foi submetido a
atrioseptostomia com colocação de stent (6 mm) para
tratamento de comunicação interatrial restritiva. No 106o
dia de vida, realizou-se operação de Norwood associada à
anastomose cavopulmonar bilateral. As bandagens foram
removidas, sem distorção das artérias pulmonares.
Conclusões: O uso clínico deste sistema inovador de
bandagem ajustável das artérias pulmonares mostrou-se
factível, seguro e eficaz. Permitiu o ajuste fino do fluxo
pulmonar de acordo com as necessidades clínicas,
proporcionando um equilíbrio preciso entre as circulações
pulmonar e sistêmica.
Descritores: Cardiopatias congênitas. Contenedores.
Assistência paliativa.  Síndrome do coração esquerdo
hipoplásico. Artéria pulmonar, cirurgia.  Dilatação com balão.
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The adjustable banding device
Our prototype is entirely made of silicone, a miniaturized
and improved device developed in the laboratories of Heart
Institute of the Hospital das Clínicas (FMUSP) from
previous experimental studies that has resulted in a more
delicate banding system for neonatal use (Figure 1) [11-19].
It consists of three parts: a banding ring, connecting tubing,
and an inflation reservoir. The banding ring is a C-shaped
hydraulic cuff, with an internal diameter of 1 mm to 5 mm and
5-mm width, and a rigid outer layer, reinforced with a Dacron
mesh, which stops it from becoming centrifugally deformed.
The cuff compresses the lumen of the pulmonary artery
when expanded, according to the volume percutaneously
injected into the subcutaneously implanted inflation
reservoir. The banding ring is potentially able to increase
by 500% in size, promoting a wide range of reversible
constriction of the banded pulmonary artery. The connecting
tubing (70 mm x 2 mm) hermetically connects the banding
ring to the inflation reservoir.
In this paper, we report the first clinical application of this
new percutaneous adjustable pulmonary artery banding
system in a newborn baby with hypoplastic left heart
syndrome, who successfully underwent initial palliation.
Neoaortic reconstruction and a bidirectional cavopulmonary
connection were successfully performed at 3.5 months of life.
oxygen saturation monitoring. A systolic pressure in the
distal pulmonary artery less than half of the systemic
pressure and an arterial oxygen saturation of 75%-85%
usually reflect an adequate balance between the pulmonary
and systemic blood flow. This may be readily achieved in
the operating room, with an open chest and under artificial
conditions. However, in the postoperative period, which
may be quite unpredictable, the fixed pulmonary bandings
do not allow for fine adjustments according to the
underlying clinical needs of the patient. Moreover, in order
to avoid hypoxemia as the infant rapidly grows up, the
balance between the pulmonary and systemic blood flows
should be adjusted, which is impossible with fixed bands.
To deal with these problems, we devised a mini banding
device that allows fine percutaneous adjustments of the
pulmonary blood flow in the postoperative period. It is
called ABS, which stands for “Assad Banding System”
(Silimed Inc., Rio de Janeiro, Brazil). This innovative
percutaneous adjustable pulmonary artery banding system
permits  fine control of the pulmonary blood flow by
accurately increasing or decreasing the cross-sectional
diameter of the pulmonary arteries. Therefore, it is adjusted
according to the underlying clinical conditions of the
patient: hypoxemia is, for instance, managed by loosening
the pulmonary artery banding circumference.
Fig. 1 - The adjustable pulmonary artery banding system is made entirely of silicone. It consists of three
parts: banding ring and inflation reservoir and connecting tube (70 mm x 2 mm)
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CASE REPORT
This was a full term female newborn, weighing 2.76 kg,
with a prenatal diagnosis of hypoplastic left heart syndrome.
A postnatal echocardiogram confirmed the intrauterine
findings: the aortic and mitral valves were atretic and
stenotic, respectively, and the diameter of the ascending
aorta was 2.5 mm. There was an unrestrictive atrial septal
defect measuring 6 mm. She initiated on a prostaglandin
infusion and her systemic saturation was 90-95% in room air
with spontaneous breathing.  Perinatal management with the
new adjustable pulmonary artery banding system had been
planned in a tertiary care center (Hospital Samaritano, Sao
Paulo, Brazil). After extensive discussions with the parents
during gestation, including explanation of the procedure’s
benefits and risks and the possibility of heart transplantation,
the new banding device was used on a compassionate basis
after obtaining approval from the local Ethics Committee and
written informed consent from parents.
The stage I operation was carried out on the fifth day of
life. Through a median sternotomy, the patient underwent
bilateral pulmonary artery banding with the new
percutaneously adjustable system (Figure 2), associated with
a reversed modified Blalock-Taussig shunt (6 mm
polytetrafluoroethylene tube) between the main pulmonary
artery and proximal innominate artery, without
cardiopulmonary bypass (Figure 3).
The strategy of stenting the arterial duct was not applied
in this case due to absence of obstructive aortic arch lesion
or coarctation. Once the two adjustable banding rings were
placed around the pulmonary arteries and the inflation
reservoirs left in the infraclavicular subcutaneous tissue,
the degree of banding ring constriction was adjusted after
sternal closure. Each band was inflated with 0.30 mL saline
solution to decrease arterial oxygen saturation to the 75%-
80% range, while breathing under a 30% inspired oxygen
fraction. The prostaglandin infusion was discontinued
following the procedure.
The patient had an uneventful postoperative course,
with no need for inotropic medications or bicarbonate.
Nitroprusside was used to control systemic hypertension.
She was weaned from mechanical ventilation on
Postoperative Day 6. She was discharged 21 days after the
operation. Three percutaneous adjustments of the banding
system were necessary during the hospital stay to keep
the arterial oxygen saturation within the 75%-85% range
(Figure 4).
Fig. 3 - Reversed modified Blalock-Taussig shunt (6 mm Goretex
tube) between the main pulmonary artery and innominate artery
performed through a mid sternotomy
Fig. 4 - Inflating reservoirs positioned in the infraclavicular area,
one for each pulmonary artery for independent percutaneous blood
flow adjustment
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Fig. 2 - Bilateral pulmonary artery banding with the new
percutaneously adjustable system (4 mm), implanted through a
mid sternotomy. The inflation buttons are to be implanted
subcutaneously in the patient’s chest wall
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The infant was followed closely with serial
echocardiographic assessment every week, which showed
progressive obstruction of the atrial septal defect. There
was no obstruction within the aortic arch and the main
pulmonary artery to the innominate artery shunt was widely
patent. There was good qualitative right ventricular function
and minimal tricuspid valve regurgitation. Therefore, on the
48th day of life, a 6 x 19 mm, pre-mounted Palmaz Genesis
stent (Cordis Co., Miami, FL) was implanted across the atrial
septal defect, with clear hemodynamic and arterial oxygen
saturation improvement (Figure 5), despite remaining in an
off-center position. After that, seven additional
percutaneous adjustments (removal of saline solution from
the reservoir) of the banding system were necessary, so
that in the last adjustment performed on the 91st day of life,
only 0.12 mL saline solution was left in each band to maintain
the arterial oxygen saturation within the recommended range
(Figure 6).
Fig. 6 - Hemodynamics and arterial oxygen saturation during
pulmonary artery banding adjustments.
PAB VOLUME = total volume injected in both inflating reservoirs;
ASD = atrial septal defect
Fig.7 - Stent pré-montado Genesis (6 X 19 mm) mostrando
proliferação intra-stent importante, com orifício residual de 3 mm.
Painel A: vista lateral, mostrando o posicionamento
descentralizado do stent no septo interatrial. AD= lado do átrio
direito, AE= lado do átrio esquerdo; Painel B: Vista superior,
mostrando a proliferação do tecido intra-stent
The patient was electively submitted to the
“comprehensive” stage II surgical palliation on the 106th
day of life. Progressive obstruction within the interatrial
stent had been noted on repeat echocardiograms before
surgery. Direct anastomosis of the main pulmonary artery
to the transverse aortic arch with no prosthetic materials
was performed along with a bidirectional cavopulmonary
connection. The anatomy of the pulmonary arteries was
well preserved with no distortions. The stent was removed
from the interatrial septum and a complete atrial septectomy
was carried out. Upon removal, inspection of the stent
displayed significant intrastent neoproliferation, leaving a
3-mm orifice that caused the restrictive blood flow through
the atrial septal defect (Figure 7). The initial postoperative
period was uneventful, with adequate saturation and
systemic cardiac output. However, on Postoperative Day
11, she was reoperated to drain a subcutaneous tissue
abscess caused by Pseudomonas aeruginosa. She remained
ASSAD, RS ET AL - A novel adjustable pulmonary artery banding
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Fig. 5 - Pre-mounted Palmaz Genesis stent (6 x 19 mm) deployed
across the atrial septal defect
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on antibiotic therapy for a total of 30 days, with good clinical
response. Oral feeding was progressively re-established and
she was discharged home on Postoperative Day 50. At
present, she is 14 months old, doing well on low doses of
vasodilators, with arterial oxygen saturation in the low 80s,
normal neurodevelopmental function, with weight and length
above the 5th percentile on growth charts, usually expected
for infants with complex congenital heart disease [20]. Total
cavopulmonary connection (Modified Fontan Surgery) is
planned for 2 years time.
DISCUSSION
To the best of our knowledge, this is the first report to
demonstrate the feasibility, safety and efficacy of the use of
the new percutaneously adjustable pulmonary artery
banding system for stage I palliation of hypoplastic left
heart syndrome in a neonate.
Prior to applying this new technique in human beings,
we extensively evaluated the feasibility and safety of different
banding devices in young goats for more than one decade,
by assessing the acute right ventricular hypertrophy [10-
12,2 ,3 ]. The cumulated knowledge of our experimental work
was crucial to test our system in a clinical setting, making
implantation technically straightforward.
Our new banding system is a biocompatible device,
which can easily be placed during an operation with no
technical difficulties. It proved to be a very efficient, simple
and precise method to percutaneously regulate the
pulmonary blood flow over time, resulting in a balanced
pulmonary and systemic circulation with adequate
saturation as the patient rapidly grew and gained weight.
The adjustments could be performed as many times as
required, both in the acute stage and in the outpatients’
setting, avoiding additional surgical interventions. These
fine and reversible adjustments can not be achieved when
using traditional surgical banding devices and techniques
that are commonly employed for patients with hypoplastic
left heart syndrome. The use of this innovative percutaneous
adjustable banding system seems to result in a more
predictable postoperative course, including in the immediate
postoperative period and the inter-stage phase, and a more
stable patient, which is highly desirable for the
comprehensive phase II operation.
One concern with any pulmonary artery banding
technique or device, including the one reported here, is the
possibility of causing vessel distortion or stenosis, which
may have a deleterious impact on subsequent cavopulmonary
operations. Fortunately, the scar tissue surrounding the
banding devices was minimal in our patient and did not result
in any of these complications. Whether this is related to the
material of the banding rings (silicone) is speculative. This
issue remains to be clarified with ongoing experience.
On the other hand, the main problem that has emerged in
this case was the postoperative infection in the
subcutaneous tissue, probably related to the presence of
the subcutaneous reservoirs. Although this was a minor
complication that was easily managed with antibiotic therapy
and drainage of the subcutaneous abscess, it is of paramount
importance to keep judiciously sterile techniques when
manipulating equipment required to inflate or deflate the
reservoirs.
The issue of progressive obstruction through the atrial
septal defect, although not related only to the new banding
system per se, was another problem in this case, which
anticipated the indication of the comprehensive stage II
operation. It is well known that even large, unobstructed
atrial septal defects in patients with hypoplastic left heart
syndrome, such as the one observed initially in the case
presented herein, generally become restrictive over time.
Stent implantation within the atrial septum has been
advocated to treat this complication [6]. The application of
this technique in our case proved to be successful for only
two months. Significant intra-stent proliferation was
observed during the phase II operation. Whether this was
related to the type of stent employed, its position (off-center)
or final diameter is speculative. Accurate diagnosis of this
complication using serial echocardiography is mandatory
since deflation of the reservoirs to loosen the pulmonary
artery bands could result in pulmonary venous congestion
and hypoxemia. It is clear that overall success of this new
banding approach is closely related to early establishment
of unrestrictive pulmonary blood flow through the atrial
septal defect. New catheter technologies must aim at creating
a reliable, unrestrictive and durable atrial communication.
We acknowledge that not having stented the duct in
order to ensure an unrestrictive systemic blood flow in this
case may be highly debatable. However, ductal stent
deployment has not been completely free of technical and
procedural complications [21] . It may not be necessary in
an uncommon and occasional patient with no aortic arch
obstructions, such as ours. In our patient, the reversed
Blalock Taussig shunt from the main pulmonary artery to
the innominate artery worked well to maintain adequate
blood flow to the coronary artery, head and neck vessels
and lower body arteries after ductal constriction. Indeed, it
has a potential to improve coronary flow dynamics [22].
The issue of how to recognize such an uncommon patient
using echocardiography remains to be better established
with greater experience.
CONCLUSION
In conclusion, the use of our innovative percutaneously
adjustable bilateral pulmonary artery banding system allowed
fine control of the pulmonary blood flow in a neonate with
ASSAD, RS ET AL - A novel adjustable pulmonary artery banding
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hypoplastic left heart syndrome undergoing phase I
palliation. This customization of the pulmonary blood flow
according to the underlying clinical needs of an infant with
rapid somatic growth seems to result in a more precise
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during the inter-stage period. Further clinical studies with a
larger number of patients and a broader spectrum of the
disease are planned in the future.
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